Risk estimation for lung cancer in Libya: analysis based on standardized norbidity ratio, poisson-gamma model, BYM model and mixture model

Alhdiri, Maryam Ahmed

Abstract

Cancer is the most rapidly spreading disease in the world, especially in developing countries, including Libya. Cancer represents a significant burden on patients, families, and their societies. This disease can be controlled if detected early. Therefore, disease mapping has recently become an important method in the fields of public health research and disease epidemiology. The correct choice of statistical model is a very important step to producing a good map of a disease. Libya was selected to perform this work and to examine its geographical variation in the incidence of lung cancer. The objective of this paper is to estimate the relative risk for lung cancer. Four statistical models to estimate the relative risk for lung cancer and population censuses of the study area for the time period 2006 to 2011 were used in this work. They are initially known as Standardized Morbidity Ratio, which is the most popular statistic, which used in the field of disease mapping, Poisson-gamma model, which is one of the earliest applications of Bayesian methodology, Besag, York and Mollie (BYM) model and Mixture model. As an initial step, this study begins by providing a review of all proposed models, which we then apply to lung cancer data in Libya. Maps, tables and graph, goodness-of-fit (GOF) were used to compare and present the preliminary results. This GOF is common in statistical modelling to compare fitted models. The main general results presented in this study show that the Poisson-gamma model, BYM model, and Mixture model can overcome the problem of the first model (SMR) when there is no observed lung cancer case in certain districts. Results show that the Mixture model is most robust and provides better relative risk estimates across a range of models.

References

1. Abusaa A (2008). First annual report population-based cancer registry 2006. Sabratha, African Oncology Institute, pp 1-60. 2. Alhdiri MA, Samat NA, Mohamed Z (2016). Mapping Libya’s prostate cancer based on the SMR method: A geographical analysis. Geografia Malays J Soc Space, 12, 118-25. 3. Alsaker MH (2013). Natural human factors plays in the incidence of Malignant tumors in the north - west of Libya. University of Tripoli, pp 1-232. 4. Bell BS, Hoskins RE, Pickle LW, Wartenberg D (2006). Current practices in spatial analysis of cancer data: Mapping health statistics to inform policymakers and the public. Int J Health Geogr, 5, 49. 5. Besag J, York J, Mollie A (1991). Bayesian image restoration with two applications in spatial statistics. Ann Inst Stat Math, 43, 1–59. 6. Bodalal Z, Azzuz R, Bendardaf R (2014). Cancers in eastern Libya: First results from Benghazi medical center. World J Gastroenterol, 20, 6293–6301. 7. Bodalal Z, Bendardaf R (2014). Colorectal carcinoma in a southern mediterranean country: The Libyan scenario. World J Gastrointest Oncol, 6, 98–103. Cancer Research UK. What is cancer?. Retrieved 10 January 2017, Available at: http://www.cancerresearchuk.org/ about-cancer/what-is-cancer. 8. Clayton DG, Kaldor J (1987). Empirical bayes estimates of age-standardised relative risks for use in disease mapping. Biometrics, 43, 671–91. 9. Elebead FM, Hamid A, Hilmi HSM, Galal H (2012). Mapping cancer disease using geographical information system (GIS) in Gezira state-Sudan. J Community Health, 37, 830-9. 10. Ferlay J, Hai RS, Freddie B, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer,127, 2893–917. 11. George JM, Po-Huang C, Tyler S, et al (2013). Use of GIS mapping as a public health tool from cholera to cancer.Health Serv Insights,6, 111–16. 12. John R, Ross H (2010). The global economic cost of cancer. Atlanta, GA: American Cancer Society and Livestrong Organization, pp 1-10. 13. Lawson A B (2006). Statistical methods in spatial epidemiology.England: Wiley, pp 1-424. 14. Lawson AB (2009). Bayesian Disease Mapping: Hierarchical Modeling in Spatial Epidemiology. Int Stat Rev, 77, 325–6. 15. Lawson AB, Biggeri AB, Boehning D, et al (2000). Disease mapping models: An empirical evaluation. Stat Med, 19,2217–41. 16. Lawson AB, Browne WJ, Vidal Rodeiro CL (2003). Disease mapping with winBUGS and MLwiN. England: John Wiley and Sons, pp1-296. 17. Lawson AB, Clark A (2002). Spatial mixture relative risk models applied to disease mapping. Stat Med, 21, 359–70. 18. Meza JL (2003). Empirical bayes estimation smoothing of relative risks in disease mapping. J Stat Plan Inference, 112, 43–62. 19. Salim E, Jaziel AR, Moore AM (2011). Lung cancer incidence in the Arab league countries: Risk factors and control. Asian Pac JCancer Prev, 12, 17–34. 20. Samat NA, Percy DF (2008). Standardized mortality and morbidity ratios and their application to Dengue disease mapping in Malaysia. In Proceedings of the Salford postgraduate annual research conference, 200–10. Manchester: Salford University. doi:9781905732715. 21. Siegel R, Elizabeth W, Otis B, Ahmedin J (2011). Cancer Statistics, 2011 the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin, 61, 212–36. 22. Spiegelhalter DJ, Best NG, Carlin BP, Der Av (2002). Bayesian measures of model complexity and fit (with discussion). J R Stat Soc Series B, 64, 583–640. 23. Washington DC (2007). Food, nutrition, physical activity, and the prevention of cancer: A global perspective / world cancer research fund; American institute for cancer research. doi:978-0-9722522-2-5. 24. World Health Origination (WHO), Cancer: Early detection ofcancer. Retrieved 13 March 2017, Available at: http://www. who.int/cancer/detection/en/.